Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
Auro Vaccines LLC
About
  2. Companies
  3. Auro Vaccines LLC
  4. Products
  5. GeneVax - Model prime/VesiculoVax - ...

GeneVax - Model prime/VesiculoVax - Boost Therapeutic Vaccine for HSV-2

SHARE

Auro Vaccines is developing a GeneVax prime/VesiculoVax boost therapeutic vaccine for herpes simplex virus type-2. This vaccine is designed to ameliorate disease and transmission by preventing HSV-2 reactivation and shedding.

Most popular related searches
therapeutic vaccine
herpes simplex
vaccination
antigen discovery
drug treatment
disease transmission
vaccine designed
vaccine design
vaccine development
infection control

Program Status:

Antigen discovery stage. Further development of this candidate is currently on hold and is available for out-licensing or co-development.

Unmet Medical Need:

Herpes simplex virus type 2 is a sexually transmitted virus that causes watery lesions in the skin and mucus membranes of the genitals. It establishes latency in neurons, from where it can sporadically reactivate to cause shedding/transmission with or without new sores. The CDC estimates that 776,000 people in the United States are newly infected each year. Currently, control is only possible with life-long drug treatment.